Millipore Sigma Vibrant Logo

MABT100 Anti-Girdin Antibody, CT, clone 10E6.1

View Products on Sigmaaldrich.com
MABT100
100 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Fulfillment and delivery delayed
Fulfillment and delivery delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWB, IH(P), ICC, IPMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABT100
      DescriptionAnti-Girdin Antibody, CT, clone 10E6.1
      Alternate Names
      • Girdin
      • Akt phosphorylation enhancer
      • Coiled-coil domain-containing protein 88A
      • G alpha-interacting vesicle-associated protein
      • GIV
      • Girders of actin filament
      • Hook-related protein 1
      • HkRP1
      Background InformationGirdin (Ccdc88a; APE, GIV, or HkRP1) is a ubiquitous protein belonging to the CCDC88 family. Girdin is an actin-binding protein which interacts with actin via its C-terminal domain, and may play a crucial role in cell motility and cytoskeleton remodeling. These effects may be regulated by a reciprocal relationship between Girdin and Akt. Akt phosphorylates Girdin, and Girdin binds to Akt and enhances phosphorylation of Akt, thereby promoting phosphorylation of Akt’s downstream targets such as GSK-3β and FOXO1A. Girdin/Akt signaling may play an important role in cancer by facilitating the proliferation of cancer cells.
      References
      Product Information
      FormatPurified
      Control
      • Human brain tissue lysate
      PresentationPurified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-Girdin, C-terminus Antibody, clone 10E6.1 is validated for use in Western Blotting, IHC(P), ICC, Immunoprecipitation for the detection of Girdin, C-terminus, clone 10E6.1.
      Key Applications
      • Western Blotting
      • Immunohistochemistry (Paraffin)
      • Immunocytochemistry
      • Immunoprecipitation
      Application NotesImmunohistochemistry Analysis: A 1:250 dilution from a representative lot detected Girdin in epithelial cells of human prostate tissue.

      Immunocytochemistry Analysis: A 1:500 dilution from a representative lot detected Girdin in HeLa cells.

      Immunoprecipitation Analysis: A representative lot immunoprecipitated Girdin in COS-7 cell lysate.
      Biological Information
      ImmunogenRecombinant protein corresponding to human Girdin.
      Clone10E6.1
      HostMouse
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes a member of the Girdin family of coiled-coil domain containing proteins. The encoded protein is an actin-binding protein that is activated by the serine/threonine kinase Akt and plays a role in cytoskeleton remodeling and cell migration. The encoded protein also enhances Akt signaling by mediating phosphoinositide 3-kinase (PI3K)-dependent activation of Akt by growth factor receptor tyrosine kinases and G protein-coupled receptors. Increased expression of this gene and phosphorylation of the encoded protein may play a role in cancer metastasis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
      Gene Symbol
      • CCDC88A
      • APE
      • GRDN
      Purification MethodProtein G Purified
      UniProt Number
      UniProt SummaryFUNCTION: Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Enhances phosphoinositide 3-kinase (PI3K)-dependent phosphorylation and kinase activity of AKT1/PKB, but does not possess kinase activity itself. Phosphorylation of AKT1/PKB thereby induces the phosphorylation of downstream effectors GSK3 and FOXO1/FKHR, and regulates DNA replication and cell proliferation. Essential for the integrity of the actin cytoskeleton and for cell migration. Required for formation of actin stress fibers and lamellipodia. May be involved in membrane sorting in the early endosome.

      SUBUNIT STRUCTURE: Interacts (via C-terminus) with DISC1; the interaction is direct. Interacts with AKT proteins; the interaction is inhibited in presence of DISC1. Homodimer. The non-phosphorylated form interacts with phosphatidylinositol 4-phosphate [PI4P] and weakly with phosphatidylinositol 3-phosphate [PI3P]. Interacts with microtubules. Interacts with actin through its C-terminal domain. Interacts with the C-terminus of AKT1/PKB.

      SUBCELLULAR LOCATION: Membrane. Cell membrane. Cytoplasm > cytosol. Cytoplasmic vesicle. Cell projection > lamellipodium. Note: Localizes to the cell membrane through interaction with phosphoinositides.

      TISSUE SPECIFICITY: Expressed ubiquitously.

      POST-TRANSLATIONAL MODIFICATION: Phosphorylation is induced by epidermal growth factor (EGF) in a phosphoinositide 3-kinase (PI3K)-dependent manner. Phosphorylation by AKT1/PKB is necessary for the delocalization from the cell membrane and for cell migration.

      SEQUENCE SIMILARITIES: Belongs to the CCDC88 family.

      SEQUENCE CAUTION: The sequence AAY14932.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence CAD97945.1 differs from that shown. Reason: Intron retention at the C-terminus. The sequence CAI46020.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended.
      Molecular Weight~216 kDa observed
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in human brain tissue lysate.

      Wesetern Blot Analysis: A 1:5000 dilution of this antibody detected Girdin in 10 µg of human brain tissue lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABT100 04053252643422

      Documentation

      Anti-Girdin Antibody, CT, clone 10E6.1 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Girdin Antibody, CT, clone 10E6.1 Certificates of Analysis

      TitleLot Number
      Anti-Girdin, C-terminus, clone 10E6.1 - 2153088 2153088
      Anti-Girdin, C-terminus, clone 10E6.1 - 2328392 2328392
      Anti-Girdin, C-terminus, clone 10E6.1 - 2366608 2366608
      Anti-Girdin, C-terminus, clone 10E6.1 - 3288500 3288500
      Anti-Girdin, C-terminus, clone 10E6.1 - 3521073 3521073
      Anti-Girdin, C-terminus, clone 10E6.1 - 3538139 3538139
      Anti-Girdin, C-terminus, clone 10E6.1 - 3715121 3715121
      Anti-Girdin, C-terminus, clone 10E6.1 - Q1988385 Q1988385
      Anti-Girdin, C-terminus, clone 10E6.1 -2496223 2496223
      Anti-Girdin, C-terminus, clone 10E6.1 -2659648 2659648

      Newsletters / Publications

      Title
      Research Focus - Volume 4 - 2012